Brief: Therapeuticsmd- On Aug 17, Michael C. Donegan, Principal Financial & Accounting Officer Of Co, Notified Of His Decision To Resign From Such Positions
18/08/2023 23:05
TherapeuticsMD Inc TXMD.O :
* THERAPEUTICSMD- ON AUG 17, MICHAEL C. DONEGAN, PRINCIPAL
FINANCIAL & ACCOUNTING OFFICER OF CO, NOTIFIED OF HIS DECISION
TO RESIGN FROM SUCH POSITIONS
* THERAPEUTICSMD INC - JOSEPH ZIEGLER SUCCEEDED DONEGAN AS
PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
Source text for Eikon: ID:
Further company coverage: TXMD.O
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract